Developer of small molecule therapeutics for the treatment of inflammatory disease and cancer.
$25 Million Aquinox Pharmaceuticals At-the-market Offering Developer of small molecule therapeutics for the treatment of inflammatory disease and cancer. Related Topics Aquinox PharmaceuticalsBiotechnologyEquity Capital MarketsHealth CareNorth AmericaPharmaceuticals – Specialty